Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Fischer Medical VenturesBOM:524743 -2.22%41 3-Year ROIIC % is 5.17 as of Mar. 2026, which is 45% below its 10-year median of 9.44. GuruFocus rates BOM:524743 with a GF Score™ of 41/100 and a GF Value™ of ₹260.24 (Possible Value Trap). The stock has 2 warning signs investors should review. Among 794 Medical Devices & Instruments companies, Fischer Medical Ventures ranks better than 55.92% on this metric.
3-Year Return on Invested Incremental Capital (3-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 3-year.
Fischer Medical Ventures's 3-Year ROIIC % for the quarter that ended in Mar. 2026 was 5.17%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
The industry rank for Fischer Medical Ventures's 3-Year ROIIC % or its related term are showing as below:
BOM:524743's 3-Year ROIIC % is ranked better than 55.92% of 794
companies
in the Medical Devices & Instruments industry
Industry Median: 1.62
vs BOM:524743: 5.17
Fischer Medical Ventures (BOM:524743) 3-Year ROIIC % Explanation
Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.
High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
Be Aware
It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.
Fischer Medical Ventures 3-Year ROIIC % Related Terms
Fischer Medical Ventures 3-Year ROIIC % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:524743 vs ABT, SYK, MDT: 3-Year ROIIC % Comparison
For the Medical Devices subindustry, Fischer Medical Ventures's 3-Year ROIIC %, along with its competitors' market caps and 3-Year ROIIC % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Fischer Medical Ventures 3-Year ROIIC % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Fischer Medical Ventures's 3-Year ROIIC % distribution charts can be found below:
* The bar in red indicates where Fischer Medical Ventures's 3-Year ROIIC % falls into.
Fischer Medical Ventures 3-Year ROIIC % Calculation
Fischer Medical Ventures's 3-Year ROIIC % for the quarter that ended in Mar. 2026 is calculated as:
3-Year ROIIC %
=
3-Year Incremental Net Operating Profit After Taxes (NOPAT)**
/
3-Year Incremental Invested Capital**
=
( 268.3365331 (Mar. 2026) - 0.153 (Mar. 2023) )
/
( 5193.532 (Mar. 2026) - 2.809 (Mar. 2023) )
=
268.1835331
/
5190.723
=
5.17%***
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** Annual data of NOPAT and Invested Capital was used to calculate 3-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.
Fischer Medical Ventures (BOM:524743) has a 3-Year ROIIC % of 5.17 as of Mar. 2026. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Fischer Medical Ventures and its competitors. This is 45% below median its historical median of 9.44. According to the industry distribution chart, Fischer Medical Ventures ranks #350 out of 794 companies in the Medical Devices & Instruments industry, placing it in the top 44.1%.
Is Fischer Medical Ventures' 3-Year ROIIC % too high?
Fischer Medical Ventures' current 3-Year ROIIC % of 5.17 is 45% below median its 10-year median of 9.44. The Medical Devices & Instruments industry median 3-Year ROIIC % is 1.62. Fischer Medical Ventures' value of 5.17 is 219.1% above this industry median. Based on the distribution chart, Fischer Medical Ventures ranks #350 out of 794 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Fischer Medical Ventures has a GF Score™ of 41/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Fischer Medical Ventures' 3-Year ROIIC % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Fischer Medical Ventures ranks #350 out of 794 companies for 3-Year ROIIC %. This puts Fischer Medical Ventures in the upper half of its industry. The industry median 3-Year ROIIC % is 1.62. Fischer Medical Ventures' value of 5.17 is 219.1% above this benchmark. While the company's 10-year median is 9.44 vs. the industry median of 1.62, Fischer Medical Ventures has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year ROIIC % for a Medical Devices & Instruments company?
The median 3-Year ROIIC % among Medical Devices & Instruments companies is 1.62, based on 794 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year ROIIC % significantly above this median, while those in the bottom quartile fall well below. However, 3-Year ROIIC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Fischer Medical Ventures's current 3-Year ROIIC % of 5.17 is 219.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year ROIIC % mean?
A high 3-Year ROIIC % can signal that a stock is expensive relative to its fundamentals. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Fischer Medical Ventures and its competitors. For the Medical Devices & Instruments industry, the median 3-Year ROIIC % is 1.62 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Fischer Medical Ventures's current 3-Year ROIIC % is 5.17, which is 45% below median its own 10-year median of 9.44. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fischer Medical Ventures stock overvalued right now?
Based on GuruFocus' analysis, Fischer Medical Ventures (BOM:524743) is currently considered Possible Value Trap. The stock's GF Value™ is ₹260.24, compared to a current price of ₹35.31 — trading 86.4% below its estimated fair value. The current 3-Year ROIIC % is 5.17, which is 45% below median its 10-year median of 9.44 and 219.1% above the Medical Devices & Instruments industry median of 1.62. Fischer Medical Ventures' overall GF Score™ is 41/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year ROIIC % calculated?
3-Year ROIIC % is calculated from a company's financial statements. For Fischer Medical Ventures (BOM:524743), the current 3-Year ROIIC % is 5.17 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Fischer Medical Ventures (BOM:524743) Overvalued in 2026?
Based on GuruFocus' analysis, Fischer Medical Ventures stock appears to be undervalued.
The current stock price of ₹35.31 is trading 86.4% below its estimated GF Value™ of ₹260.24.
GuruFocus considers Fischer Medical Ventures to be Possible Value Trap.
Key valuation signals for BOM:524743:
3-Year ROIIC %: 5.17 (45% below median its 10-year median of 9.44)
GF Value™: ₹260.24 vs. price of ₹35.31 (86.4% below fair value)
Industry Position: 219.1% above the Medical Devices & Instruments median (#350 of 794)
No single metric tells the full story. See the BOM:524743 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Fischer Medical Ventures Ltd is engaged in developing and trading of Medical Equipment including cutting-edge Magnetic Resonance Imaging (MRI) systems in India.
41GF Score
Get the complete analysis for BOM:524743
3-Year ROIIC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:524743 has been successfully added to your 
